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 Inpatient and outpatient rehabilitation 
for patients with rheumatoid arthritis: 
a clinical and economic assessment 
 Norelee  Kennedy  PhD1 ,  Emma  Stokes  PhD2 ,  Eamon  O’Shea3 , 
 Thomas Brendan  Murphy4 ,  Barry  Bresnihan5 ,  Oliver  FitzGerald 5,6
 Summary 
 The aim of this study was to compare 
inpatient and outpatient rehabilitation for 
patients with active rheumatoid arthritis 
from clinical and cost perspectives. 
 A single-centre, randomised trial design 
was used. Data were completed at 
baseline, post treatment and at 6 months 
follow-up. The primary outcome was 
the Arthritis Impact Measurement 
Scale 2. Several other disease activity, 
functional and quality of life measures 
were also assessed (erythrocyte 
sedimentation rate, C-reactive protein, 
visual analogue scale for pain, early 
morning stiffness, tender and swollen 
joint count, grip strength, timed 
‘Up and Go’ test and Schedule for the 
Evaluation of the Individual Quality 
of Life—Direct Weighting). All direct and 
indirect costs were measured. A total of 
47 subjects were randomised to the study. 
 No sustained signifi cant differences were 
detected between the two groups for the 
primary or secondary measures at the 
end of treatment or at follow-up. Total 
inpatient costs (€81,590) were more than 
three times higher than total outpatient 
costs (€25,450). 
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 Introduction 
 Rheumatoid arthritis (RA) is a chronic 
infl ammatory disease leading to 
considerable morbidity in terms of pain, 
fatigue, functional disability and 
reduced quality of life in addition to 
psychological, social and economic effects. 
Multidisciplinary rehabilitation is an 
essential component of the management 
of RA 1, 2 , addressing the multifaceted 
impact of the disease. A number of studies 
have been undertaken to investigate the 
effect of different settings (inpatient or 
outpatient) in managing RA. Studies 
comparing intensive inpatient care 
with regular (primarily rheumatologist 
and physiotherapist) outpatient care 3–7 
found that inpatient care was more 
effective. However, the studies had many 
methodological problems, including lack of 
randomisation 3–6 and lack of concealment 
of assessors 3–5 , 7 . Other studies 8–10 
investigating intensive inpatient and 
outpatient care found the two settings 
to be equally effective 9, 10 , with one study 8 
concluded that intensive inpatient care 
supplemented with follow-up outpatient 
care was more effective than inpatient 
care alone. 
 Intensive rehabilitation, particularly when 
delivered on an inpatient basis, is 
expensive and time consuming for patients. 
A recent randomised controlled trial in The 
Netherlands 11 of patients with RA managed 
in intensive inpatient or day patient 
settings or in an outpatient setting with 
care primarily delivered by a nurse 
specialist showed no difference in any 
outcomes measured (functional status, 
quality of life, health utility or disease 
activity). Provision of care by a nurse 
specialist, whilst reducing the intensity 
of care, did not, however, provide 
a multidisciplinary approach to 
rehabilitation. It is thus necessary 
to examine the effect of extended 
multidisciplinary outpatient care 
delivered by a number of healthcare 
professionals (medical and nursing 
personnel, physiotherapists, occupational 
therapists, social workers, orthotists) 
on clinical outcomes. 
 It is also important to assess the economic 
implications of different care regimens for 
the treatment of RA. Costs and outcomes 
need to be examined to ascertain the cost 
effectiveness of alternative regimens of 
care. This is particularly important for 
Ireland given the increasing emphasis on 
value for money in the provision of health 
and social care services. Costs of outpatient 
care are lower than intensive inpatient and 
outpatient programmes owing to the 
removal of the overnight stay and the 
lower intensity of treatment from both 
settings. The recent randomised study 
in The Netherlands 12 found that costs 
involving nurse specialist care 
(€212 for three visits of 3 hours per visit) 
were considerably lower than intensive 
care programmes (€4,961 total costs per 
study inpatient and €4,055 total costs per 
study outpatient). Total societal inpatient 
costs 2 years later remained higher than 
total societal outpatient costs (€22,448 vs. 
€16,896) and total societal nurse specialist 
costs (€11,572). A UK study 10 conducted 
in the late 1990s found that costs were 
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slightly higher following intensive 
inpatient care (£2,021) than following 
intensive outpatient care (£1,789). 
Higher inpatient costs were also reported 
in two other studies ($5,417 vs. $459 5 ; 
$5,000 vs. $802 8 ), demonstrating the 
high costs associated with inpatient care. 
 This paper compares intensive 
multidisciplinary team (MDT) inpatient 
care with extended multidisciplinary 
outpatient care for patients with RA based 
on a single-centre randomised trial of 
47 patients. Outcomes were assessed at 
baseline, post treatment and 6 months 
follow-up. Costs were assigned for 
all resource use, including non-market 
interventions. This is the fi rst study for 
Ireland in this important area and is 
a contribution to the small but growing 
international literature on the cost 
effectiveness of various treatment 
regimens for RA. 
 Methods 
 Subjects 
 Subjects recruited from the rheumatology 
outpatient clinic of one hospital were 
considered for entry to the study between 
September 2000 and July 2002. Subjects 
had a defi nite diagnosis of RA (as defi ned 
by the 1987 American College of 
Rheumatology criteria 13 ) and required 
MDT care for management of their disease. 
All subjects were over the age of 18 years 
and resided within travelling distance of 
the outpatient facility. Exclusion criteria for 
the study included an indefi nite diagnosis 
of RA and inability to travel to attend the 
outpatient facility. All subjects gave written 
informed consent to participate prior to 
randomisation to either inpatient or 
outpatient rehabilitation. Participants were 
randomised using a biased coin design 14–17 . 
 Clinical assessment 
 Assessments were conducted at baseline, 
post treatment and at 6 months follow-up. 
Timing of the post-treatment assessment 
occurred when the patient was discharged 
from the relevant setting. Thus, there was 
not a defi ned length of time between these 
two assessments. Assessments were 
conducted by the researcher, who was not 
blinded to subject group allocation as the 
two settings were in different locations. 
Owing the different locations of the two 
settings, healthcare personnel involved in 
the delivery of patient care and participants 
were not blinded to group allocation. 
 The Arthritis Impact Measurement Scale 2 
(AIMS2) was the primary outcome 
measure. It is a disease-specifi c measure of 
physical, social and emotional well-being 18 . 
Secondary outcome measures included 
erythrocyte sedimentation rate (ESR), 
C-reactive protein (CRP ) , pain using a 
visual analogue scale, early morning 
stiffness, grip strength, 28 tender and 
swollen joint count, timed ‘Up and Go’ test 
(TUG) and the Schedule for the Evaluation 
of the Individual Quality of Life—Direct 
Weighting (SEIQoL-DW) 19 . To the author’s 
knowledge this is the fi rst intervention study 
that used SEIQoL-DW for patients with RA. 
 Treatment regimens 
 Inpatient rehabilitation was provided in 
an inpatient unit by a MDT consisting of 
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medical and nursing personnel, 
physiotherapists, occupational therapists 
and a social worker. Hydrotherapy was 
also available to all inpatients. Subjects 
received daily physiotherapy, with 
occupational therapy and social work 
provided on an appointment basis. 
Weekly MDT meetings were held to 
discuss patient caseloads. Length of stay 
and thus discharge were determined by 
the MDT at their weekly team meetings. 
No personnel involved with that 
decision making were involved in 
recruiting, allocating or assessing study 
participants. Outpatient treatment was 
provided on a multidisciplinary 
appointment basis, which included 
medical, nursing, physiotherapy, 
occupational therapy and social work 
personnel. Regular team meetings were 
not held as per the inpatient setting. 
Hydrotherapy was not provided in 
the outpatient setting. 
 Cost analysis 
 Both direct and indirect costs associated 
with the delivery of care in both settings 
were recorded concurrently with the 
clinical trial. Direct costs recorded 
included pay costs, non-pay costs and 
capital costs. Indirect costs included 
costs borne by the patient such as travel 
expenses and loss of earnings. 
 Data were recorded from patient medical 
charts, physiotherapy notes and time sheets 
given to the relevant health professionals 
involved in the provision of care to the 
patient. In addition, patients were given 
diaries to record resource utilisation 
if attending the outpatient facility. 
Information recorded in these diaries 
included travel expenses, time off work, 
home help costs, childcare costs, 
General Practitioner (GP) expenses 
and carer’s costs. 
 As this study commenced in 2000 and 
completion of data collection was in 2003, 
and the majority of costs occurred in 2002, 
2002 was used as the cost base. Thus, where 
necessary, costs that occurred prior to 2002 
were uprated to account for changes in the 
Euro changeover and also to account for 
infl ation, according to the Central Bank of 
Ireland Consumer Price Index. 
 Direct costs 
 Pay costs 
 Pay costs were measured based on the 
number of hours of time spent by each 
health professional (rheumatologists, 
non-consultant hospital doctors, nurses, 
physiotherapists, occupational therapists, 
social workers, podiatrist, chiropodist, 
care assistants) and other staff (porters, 
administration staff) with the study 
patients. Salary costs were obtained from 
the Impact Union Pay and Salary scales 
(2002). Wage costs for care assistants 
and porters were obtained from the 
Human Resources Department and 
Head of Portering Services, respectively, 
in the inpatient facility. 
 The numbers and type of (home or surgery) 
GP visits were recorded. The cost of 
a GP visit to a non-medical card patient 
in Dublin in 2002 was used as the market 
value for GP visits. Patients who benefi ted 
from home-help services were asked to record 
the use of this service, which was then 
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valued at prevailing hourly pay rates. 
Similarly, the number of public health 
nurse visits to each patient was recorded, 
in addition to the length of each visit, 
and valued accordingly. The use of 
alternative medicines/therapy such as 
acupuncture, holistic health etc. was 
also recorded and valued. 
 Non-pay costs 
 Medication usage by each patient in the 
study was recorded. The name of the 
drug, the dosage and the number of 
times administered were recorded from 
patient medical records. The value of the 
medications used was determined using 
a 2002 copy of Monthly Index of Medical 
Specialities (MIMS). The number and 
type of X-rays, bone scans and blood tests 
taken for each patient in the study was 
recorded from patient medical records. 
The market value for each of these was 
obtained from the radiology department 
of a private hospital. 
 The capital and equipment costs of the 
inpatient unit were determined from the 
accounts departments 20 . These costs were 
apportioned in line with the percentage 
of patients attending the inpatient facility 
with RA (51%). The costs of the 
hydrotherapy pool (initial costs and 
ongoing maintenance costs) were also 
estimated. An annual discount rate of 
5% was used in the initial calculation of 
an equivalent daily cost. The impact of 
a 3 and 7% discount rate was examined in 
the sensitivity analysis. The accounts 
department of outpatient facility provided 
fi gures on the capital and equipment 
costs. An equivalent annual cost and 
subsequently an equivalent daily cost 
were calculated and 25% of the costs 
were allocated to patients with RA. 
 Admission expenses (cost of toiletries, 
clothing, nightwear etc. purchased by the 
patient for their admission to the inpatient 
unit) were valued based on the amount 
paid by the individual on purchase. 
Any special aids purchased by the patient 
on the recommendation of their therapist 
were also recorded. Such items were 
valued based on the amount paid by the 
patient for their purchase. Attendance 
with the podiatrist for prescription of 
custom-made footwear was also 
recorded. Costs of orthotics provided 
to each patient were obtained from 
administrative records. 
 Shared costs/overheads 
 Costs of inpatient overheads (light, heat, 
laundry, household, catering, security etc.) 
were estimated based on data supplied 
by the accounts departments of the 
two facilities. Because of joint production, 
it was necessary to allocate the costs 
based on the percentage of patients 
with RA attending the two settings in 
2002 (51% inpatient unit and 25% 
outpatient facility). These fi gures 
(51 and 25%) were used in allocation 
of all shared costs. The outpatient facility 
is a stand-alone building on the grounds 
of a large Dublin teaching hospital. 
A number of clinical services are also 
provided in this outpatient facility, 
including the rheumatology outpatient 
clinics, the breast clinic and a portion of 
the services provided by the physiotherapy 
and occupational departments. 
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 Indirect costs 
 There are likely to be signifi cant 
opportunity costs associated with 
attendance for treatment at RA facilities, 
both inpatient and outpatient. Employment 
status was recorded for each patient. 
For patients who were employed full-time 
at the time of attendance for treatment, 
the average weekly industrial wage of 
€494.58 21 was used to calculate loss of 
earnings during the period of treatment. 
For patients who were employed on a 
part-time basis, one-half of the average 
weekly industrial wage (€247.29) was used 
to estimate loss of earnings. A number of 
patients were unemployed, retired or on 
disability pensions. For these patients, a 
value of one-quarter of the average weekly 
industrial wage (€123.64) was used to 
calculate their loss of earnings, equivalent 
to lost leisure time valuation. The cost of 
attendance for people engaged in home 
duties was based on a replacement cost 
methodology based on what it would cost 
to replace them in home duties while 
attending the facility. Similarly, childcare 
costs were estimated based on the market 
value of such replacement care while 
people attended the facility. 
 Each patient was asked to record any 
travel expenses incurred, for example 
taxi fares, bus ticket costs or the number 
of miles from home to the treatment facility. 
In the case where patients provided their 
own transport or were driven for treatment 
by a family member or friend, the number 
of miles taken by the journey was 
multiplied by the Department of Social 
Welfare mileage allowance (93.04 cent) 
to determine the total costs of travel. 
An average per-patient cost was then 
calculated for each group. 
 The valuation of carer time was based on 
work previously conducted 22 , which 
estimated carer and voluntary work at an 
opportunity cost of €2.18/hour (this fi gure 
has been uprated to account for the Euro 
changeover and for infl ation). Sensitivity 
analysis based on replacement cost was 
also applied to informal care provision. 
 Statistical analysis 
 Statistical analysis was conducted using 
Minitab statistical software, version 14. 
Sample size calculations were conducted 
using data from the pilot study for the 
AIMS2. To test clinical equivalence, the 
largest acceptable clinical difference in 
outcome between the two groups was 
defi ned as 20% on the AIMS2. A total 
sample size of 42 was required to detect 
this difference between the groups, with a 
power of 80% at the  p <0.05 level (two-tailed 
test). Baseline characteristics of age and 
disease duration were compared using 
two-sample  t -tests, whilst functional 
classifi cation* and gender were compared 
using a Mann–Whitney test. Non-normally 
distributed data (ESR, CRP, grip strength 
and TUG) were log-transformed before 
analysis. Back-transformed data are 
presented for these outcome measures. 
 * American College of Rheumatology classifi cation of global functional status in RA: Class I, completely able to perform usual activities of 
daily living (self-care, vocational and avocational); Class II, able to perform usual self-care and vocational activities, but limited in avocational 
activities; Class III, able to perform usual self-care activities, but limited in vocational and avocational activities; and Class IV, limited in ability to 
perform usual self-care, vocational and avocational activities. 
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To adjust for baseline scores, analysis of 
covariance was used to compare outcome 
between the two groups at end of treatment 
and at follow-up. Analysis was based on 
intention-to-treat. The last observation 
carried forward imputation technique 
was used to assess the impact of missing 
data. All comparisons of outcome scores 
between inpatient and outpatient groups 
are presented as the difference in means 
with 95% confi dence interval (CI), after 
adjusting for baseline differences in 
outcome. Ethical approval was sought 
and granted for the study. The study 
procedures were in accordance with 
the Declaration of Helsinki 2000. 
 Results 
 A total of 55 subjects were considered for 
entry to the study over a period of 
23 months. The fl ow of participants 
through the study using AIMS2 data is 
shown in  Figure 1 . The demographic 
profi le of the 47 subjects randomised to 
the study (25 inpatients and 22 outpatients) 
is shown in  Table 1 . No signifi cant 
differences were found between the 
two groups for age ( p =0.632), disease 
duration ( p =0.475), gender ( p =0.430) 
or functional classifi cation ( p =0.420). 
 Rehabilitation programme 
 Mean length of stay in the inpatient unit 
was 13.14 days (range 4–22 days). 
All inpatients received medical and 
nursing care, physiotherapy (including 
hydrotherapy) and occupational therapy 
treatment. Eight inpatients were seen by 
the social worker. The mean number of 
outpatient appointments was 5.7 
(range 3–9 appointments). These 
appointments occurred on a weekly basis 
over a 6-week period. All outpatients 
received physiotherapy treatment and 
were reviewed by the medical team 
before discharge, 16 outpatients received 
occupational therapy, 5 patients were seen 
by the nurse specialist and 1 outpatient 
was seen by the social worker. 
 During the treatment period, 5 inpatients 
and 2 outpatients were started on a 
disease-modifying antirheumatic drug 
(DMARD), 3 inpatients and 2 outpatients 
had their DMARD dosage increased, 
whilst 13 inpatients and 11 outpatients 
had no change to their DMARD. A total of 
8 inpatients were taking steroids during 
the treatment period (mean dose of 
deltacortril 6.25 mg/day) compared with 
6 outpatients (mean dose of deltacortril 
7.9 mg/day). One outpatient was started 
on an anti-tumour necrosis factor (TNF) 
therapy (infl iximab) and received 
two doses of the treatment during the 
rehabilitation period. Four inpatients 
received joint injections during their stays 
in the inpatient unit, whilst 1 outpatient 
received joint injections during treatment. 
 During the follow-up phase, 15 inpatients 
and 14 outpatients had no change in 
medication. One inpatient and 1 
outpatient started on MTX, whilst 
1 inpatient stopped their DMARD 
and one had their DMARD dose decreased. 
One outpatient stopped steroid medication. 
Administration of the anti-TNF therapy 
for the one outpatient continued 
throughout the follow-up period. 
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 Clinical analysis 
 At baseline there were no signifi cant 
differences between the groups in outcome 
measures ( Table 2 ) for the primary outcome 
(AIMS2) or for any of the secondary 
measures. At the end of treatment and at 
follow-up, no signifi cant differences 
between the two groups were found for the 
primary measure (AIMS2) ( Table 3 ). For the 
secondary measures, only CRP showed a 
signifi cant difference between the two 
groups at follow-up (adjusted difference in 
means 2.463; 95% CI 0.011–1.792) ( Table 3 ). 
Analysis with imputation of missing 
values did change any of the fi ndings. 
 Cost analysis 
 Total inpatient costs were more than 
three times higher than total outpatient 
costs ( Table 4 ). Inpatient pay costs were 
Not randomised (n=8)
Reasons: n=5 unwilling to travel to
outpatient facility
n=3 unable to attend inpatient facility
Received inpatient treatment as
allocated (n=21)
Did not receive inpatient
treatment as allocated (n=4)
Received outpatient treatment
as allocated (n=19)
Did not receive outpatient
treatment as allocated (n=3)
Primary outcome: AIMS2
Baseline (n=19)
Start (n=20)
Finish (n=21)
Follow-up (n=15)
Primary outcome: AIMS2
Baseline (n=19)
Start (n=17)
Finish (n=18)
Follow-up (n=15)
Withdrawn before intervention
(n=4)
Lost to follow-up (n=1) 
Withdrawn before intervention
(n=3)
Lost to follow-up (n=1) 
Completed trial (n=20) Completed trial (n=18)
Randomised
Eligible patients (n=55)
 Figure 1.  Participant fl ow and follow-up diagram. 
AIMS2, Arthritis Impact Measurement Scale 2. 
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seven times higher than the equivalent 
costs in the outpatient setting and also 
accounted for almost 50% of the total costs 
in that setting. X-ray costs in the inpatient 
setting were almost four times that of the 
outpatient setting. Drug costs were 
relatively low in both settings. Overheads 
in the inpatient setting accounted for 
€11,872, refl ecting the intensity of the 
inpatient stay. Work foregone costs in the 
inpatient group were signifi cantly higher 
than for the outpatient group. The average 
cost per patient from start to fi nish of 
treatment in the inpatient setting was 
€3,263 compared with €1,293 in the 
outpatient setting. In the follow-up period, 
one outpatient was admitted to hospital 
following a fracture of the tibia, unrelated 
to his diagnosis. 
 A sensitivity analysis was conducted to 
test the robustness of the results, as there 
were a number of areas of uncertainty with 
respect to the estimation of costs. These 
areas were mainly in relation to buildings, 
equipment and homemaker costs. 
 Table 1. Demographic profi le of study participants. 
 Inpatients (n=25)  Outpatients (n=22)  p-value 
Age (years) (mean ( SD )) 58.8 (8.8) 60.4 (12.3) 0.632
Disease duration (years) (mean ( SD )) 14.6 (9.8) 12.5 (9.7) 0.475
Sex 7 male/18 female 4 male/18 female 0.430
Functional classifi cation 0.420
 I 0 0
 II 12 11
 III 11 10
 IV 2 1
 SD , standard deviation.
 Table 2. Baseline values (mean (standard deviation)) for both groups for all clinical measures. 
 Measure  Inpatient  Outpatient 
AIMS2 (0–100; lower score better) 60.46 (17.74) 52.81 (16.82)
ESR (mm/Hg) 31.32 (23.61) 26.33 (18.22)
CRP (mmol/l) 31.12 (35.68) 23.94 (21.25)
EMS (minutes) 66.70 (57.50) 71.10 (82.50)
Grip strength (KPa) 11.27 (6.26) 10.63 (9.26)
VAS for pain (0–10 cm) 4.60 (2.50) 3.80 (2.40)
Swollen joint count (0–64) 8.20 (4.87) 10.41 (6.53)
Tender joint count (0–64) 8.64 (6.28) 9.95 (7.82)
TUG (seconds) 13.77 (4.89) 14.37 (7.09)
SEIQoL (0–100; higher score better) 55.44 (25.12) 55.31 (19.27)
AIMS2, Arthritis Impact Measurement Scale 2; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; 
EMS, early morning stiffness; VAS, visual analogue scale; TUG, timed ‘Up and Go’ test; 
SEIQoL, Schedule for the Evaluation of the Individual Quality of Life.
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Two differing discount rates were used 
in the sensitivity analysis, 3 and 7%. 
The additional analysis did not change 
the conclusion from the original results. 
 Discussion 
 This study shows that over a 6-month 
follow-up period, no sustained differences 
in clinical effectiveness were observed 
between inpatient MDT care and extended 
multidisciplinary outpatient care. Both 
interventions had a positive effect on the 
functional ability of patients with RA, 
their disease activity and quality of life. 
The provision of rehabilitation in the 
inpatient setting was three times more 
costly than in the outpatient setting. 
 The fi nding of similarity of clinical outcome 
between intensive inpatient and outpatient 
 Table 4. Total costs recorded in both settings .
 Costs  Inpatient total (€)  Outpatient total (€) 
Pay 38,723 5,384
Medication 707 421
Blood tests 3,350 2,785
X-rays 4,920 1,310
Shared overheads 11,872 1,407
Capital 2,271 1,016
Work foregone 13,898 5,635
Other indirect (carer time, travel, household consumption) 3,201 6,894
Other 2,648 598
Total cost 81,590 25,450
Average per capita cost 3,263 1,293
 Table 3. Clinical outcomes: adjusted difference in means (95% confi dence interval) from baseline. 
 End of treatment  Follow-up 
AIMS2 (0–100; lower score better) 3.65 (–5.68, 12.98) –0.04 (–11.79, 11.71)
ESR (mm/Hg) 1.45 (–0.03, 0.78) 1.52 (–0.17, 1.01)
CRP (mmol/l) 1.16 (–0.39, 0.71) 2.46 (0.01, 1.79)
EMS (minutes) 9.28 (–23.53, 42.08) 16.05 (–47.20, 79.29)
Grip strength (KPa) 1.14 (–0.19, 0.44) 0.99 (–0.35, 0.32)
VAS for pain (0–10 cm) 0.52 (–0.68, 1.72) –0.19 (–2.17, 1.78)
Swollen joint count (0–64) 1.50 (–1.90, 4.91) 3.19 (–0.49, 6.87)
Tender joint count (0–64) 0.37 (–1.78, 2.53) 1.67 (–1.66, 4.99)
TUG (seconds) 2.57 (–0.03, 0.22) 1.12 (–0.05, 0.27)
SEIQoL (0–100; higher score better) –6.63 (–17.98, 4.72) –0.21 (–13.10, 12.69)
AIMS2, Arthritis Impact Measurement Scale 2; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; 
EMS, early morning stiffness; VAS, visual analogue scale; TUG, timed ‘Up and Go’ test; 
SEIQoL, Schedule for the Evaluation of the Individual Quality of Life.
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care in this study is consistent with results 
reported in other studies 10, 11 . This study 
differed from previously conducted studies 
in that the type of outpatient care delivered 
was on an extended outpatient approach 
involving more healthcare professionals 
than previous studies 4–8 , 11 . Outpatient 
care in the studies of regular outpatient 
care involved care provided by a 
physicians/rheumatologists and 
physiotherapists. In this study, outpatient 
care was provided for a mean of 5.7 
appointments with different healthcare 
professionals over a 6-week period. 
The key difference in this extended 
outpatient care compared with traditional 
outpatient care was the involvement of 
more healthcare professionals in the 
delivery of care (rheumatologists, 
physiotherapists, occupational therapists, 
social workers, clinical nurse specialists, 
orthotists), with lower intensity than that 
provided in an inpatient setting. Patients 
were involved in decision making about 
treatment times, allowing them more 
fl exibility when receiving treatment. 
Differences from intensive inpatient 
MDT care included the absence of a regular 
team meeting to discuss patients and the 
absence of a hydrotherapy pool. The 
extended outpatient care of this study also 
differs from clinical nurse specialist 11 care 
as the clinical nurse specialist is not the 
primary care giver. This study does, 
however, add to the conclusions of the 
study involving clinical nurse specialist 
care by showing that benefi cial care can be 
delivered to patients with RA on a less 
intensive outpatient basis. This is particularly 
noteworthy in light of the higher costs 
incurred in the inpatient setting. 
The higher inpatient costs found in this 
study are consistent with results from other 
studies which found that inpatient costs 
were higher than outpatient costs 5, 6, 8, 10, 12 . 
Total outpatient (regular outpatient care) 
costs were 15.8% of total inpatient costs in 
a previously reported study 6 . In this study, 
the high inpatient costs were mainly 
attributable to salary costs (approximately 
50% of total inpatient costs), a feature 
of inpatient care. X-ray costs were 
four times higher in the inpatient setting, 
perhaps attributable to the ease of access 
to the radiology department in the 
inpatient setting, which is a smaller 
facility than the outpatient facility. 
Travel costs in the outpatient setting 
were double the equivalent inpatient 
cost and represent a transfer of cost to 
the patient in the delivery of care in 
this setting. Higher costs are only 
acceptable if they are accompanied by 
greater effectiveness. In this study, 
distinct and sustained differences in 
outcome were not seen between the 
two settings despite the higher cost of 
inpatient care. 
 There is confl icting evidence regarding 
the duration of benefi t from rehabilitation 
for RA. Improvements in inpatients and 
outpatients at follow-up compared with 
baseline were found in a number of 
studies 6 ,10, 11 , with another study 10 reporting 
deterioration at follow-up (1 year) with 
a signifi cant deterioration in function and 
disease activity in each group. Similar 
to this study, there were no differences 
between the two groups at follow-up. 
Inpatients had a greater improvement at 
follow-up in one study only 7 . The duration 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
Rehabilitation in patients with rheumatoid arthritis
12 © 2007 Informa UK Ltd
of follow-up is variable between studies 
(0.5 years 6 , 2 years 8 , 1 year 10, 11 ), making 
direct comparisons diffi cult. 
 Strengths and limitations 
 This is the fi rst study based in Ireland 
to examine costs associated with the 
provision of multidisciplinary 
rehabilitation for patients with RA. 
It provides valuable information on the 
costs associated with the provision of care 
for this patient group. It does have some 
limitations; nevertheless, the authors 
believe the strengths of the study in other 
aspects of its design make the results 
noteworthy. This was a single-centre trial in 
a country with a population of 
approximately 4 million, 1% of whom are 
estimated to have RA. There are only two 
inpatient MDT settings in Ireland, thus 
accessing large numbers of patients was 
limited from the outset. In addition, a 
slower than predicted throughput of 
patients meeting the inclusion criteria and 
a restricted time frame prevented the 
inclusion of more subjects. Second, changes 
in drug use were not controlled for in either 
setting. However, documentation of drug 
use during treatment and follow-up 
showed that drug use was generally similar 
in both groups, except for one outpatient 
who started on anti-TNF therapy. The effect 
of this one patient on the overall results 
was not measured. Also, it was not possible 
to blind the assessor to group allocation 
owing the participants receiving treatment 
at different sites and it was not feasible to 
bring participants to a neutral venue for 
assessment. However, the assessor was not 
involved in delivering care to participants, 
thus reducing assessor bias. 
 Lastly, the Health Assessment 
Questionnaire (HAQ) was not included as 
an outcome measure as it was thought that 
the AIMS2, having a functional aspect, 
would suffi ce. Omission of the HAQ reduces 
the identifi cation of functional disability 
and the extent to which the study can be 
compared with other studies in this area. 
 Conclusion 
 In summary, this study, despite its small 
sample size, does have some important 
contributions to make to the topic of 
inpatient and outpatient multidisciplinary 
rehabilitation. It verifi es the results of 
previously conducted studies reporting 
similar clinical outcomes when comparing 
inpatient and outpatient rehabilitation. 
It builds on other research by showing 
that an extended multidisciplinary 
outpatient approach offering fl exibility 
in the delivery of rehabilitation is a viable 
and less costly alternative to more 
intensive inpatient approaches. 
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